Recommendations for medical management of hereditary breast and ovarian cancer: The French National Ad Hoc Committee
Open Access
- 1 September 1998
- journal article
- guideline
- Published by Elsevier BV in Annals of Oncology
- Vol. 9 (9), 939-950
- https://doi.org/10.1023/a:1008389021382
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Probability of Carrying a Mutation of Breast-Ovarian Cancer Gene BRCA1 Based on Family HistoryJNCI Journal of the National Cancer Institute, 1997
- Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 geneNature Genetics, 1997
- Attitudes towards cancer predictive testing and transmission of information to the family.Journal of Medical Genetics, 1996
- The advent of the ‘unpatients’Nature Medicine, 1996
- Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlationNature Genetics, 1995
- Health policy approaches to measuring and valuing human life: conceptual and ethical issues.American Journal of Public Health, 1995
- Autosomal dominant inheritance of early-onset breast cancer. Implications for risk predictionCancer, 1994
- Communicating probabilistic information to cancer patients: Is there ‘noise’ on the line?Social Science & Medicine (1982), 1991
- Strategies for multilocus linkage analysis in humans.Proceedings of the National Academy of Sciences of the United States of America, 1984